These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28477079)

  • 21. Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy.
    Scheltema MJ; Chang JI; Böhm M; van den Bos W; Blazevski A; Gielchinsky I; Kalsbeek AMF; van Leeuwen PJ; Nguyen TV; de Reijke TM; Siriwardana AR; Thompson JE; de la Rosette JJ; Stricker PD
    World J Urol; 2018 Sep; 36(9):1383-1389. PubMed ID: 29594551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Multicenter, Randomized, Single-blind, 2-Arm Intervention Study Evaluating the Adverse Events and Quality of Life After Irreversible Electroporation for the Ablation of Localized Low-intermediate Risk Prostate Cancer.
    de la Rosette J; Dominguez-Escrig J; Zhang K; Teoh J; Barret E; Ramon-Borja JC; Muir G; Bohr J; de Reijke T; Ng CF; Leung CH; Sanchez-Salas R; Laguna P
    J Urol; 2023 Feb; 209(2):347-353. PubMed ID: 36441776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedback.
    Scheltema MJ; Postema AW; de Bruin DM; Buijs M; Engelbrecht MR; Laguna MP; Wijkstra H; de Reijke TM; de la Rosette JJMCH
    Diagn Interv Radiol; 2017; 23(5):365-370. PubMed ID: 28830850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Irreversible electroporation: implications for prostate ablation.
    Onik G; Mikus P; Rubinsky B
    Technol Cancer Res Treat; 2007 Aug; 6(4):295-300. PubMed ID: 17668936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer.
    Murray KS; Ehdaie B; Musser J; Mashni J; Srimathveeravalli G; Durack JC; Solomon SB; Coleman JA
    J Urol; 2016 Sep; 196(3):883-90. PubMed ID: 27113966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel platinum bipolar electrode for irreversible electroporation in prostate cancer: preclinical study in the beagle prostate.
    Lim B; Kim HB; Jeong S; Kim SH; Kang JM; Park Y; Won DS; Kim JW; Ryu DS; Kim Y; Park JH; Kim CS
    Sci Rep; 2021 Aug; 11(1):17194. PubMed ID: 34433890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel focal therapy treatment options for prostate cancer.
    Werntz RP; Eggener SE
    Curr Opin Urol; 2018 Mar; 28(2):178-183. PubMed ID: 29232270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Irreversible electroporation: a new form of image-guided tumour ablation].
    Scheffer H; Nielsen K; van Tilborg A; Vieveen JM; van den Tol MP; Meijerink MR
    Ned Tijdschr Geneeskd; 2014; 158():A7176. PubMed ID: 24518847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial.
    Wendler JJ; Ricke J; Pech M; Fischbach F; Jürgens J; Siedentopf S; Roessner A; Porsch M; Baumunk D; Schostak M; Köllermann J; Liehr UB
    Cardiovasc Intervent Radiol; 2016 Feb; 39(2):239-50. PubMed ID: 26341653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focal irreversible electroporation as primary treatment for localized prostate cancer.
    van den Bos W; Scheltema MJ; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD
    BJU Int; 2018 May; 121(5):716-724. PubMed ID: 28796935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update on focal therapy for prostate cancer.
    Perera M; Krishnananthan N; Lindner U; Lawrentschuk N
    Nat Rev Urol; 2016 Nov; 13(11):641-653. PubMed ID: 27670618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partial gland ablation in the management of prostate cancer: a review.
    McClure TD; Margolis DJ; Hu JC
    Curr Opin Urol; 2017 Mar; 27(2):156-160. PubMed ID: 28033149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomes.
    Blazevski A; Gondoputro W; Scheltema MJ; Amin A; Geboers B; Barreto D; Haynes AM; Shnier R; Delprado W; Agrawal S; Thompson JE; Stricker PD
    BMC Urol; 2022 Mar; 22(1):28. PubMed ID: 35236338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study).
    Wendler JJ; Pech M; Fischbach F; Jürgens J; Friebe B; Baumunk D; Porsch M; Blaschke S; Schindele D; Siedentopf S; Ricke J; Schostak M; Köllermann J; Liehr UB
    Urology; 2018 Apr; 114():224-232. PubMed ID: 29305201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Irreversible electroporation and sarcomas: where do we stand?
    Vailas M; Syllaios A; Hashemaki N; Sotiropoulou M; Schizas D; Papalampros A; Felekouras E; Pikoulis E
    J BUON; 2019; 24(4):1354-1359. PubMed ID: 31646777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combinatorial effect of radium-223 and irreversible electroporation on prostate cancer bone metastasis in mice.
    Rojo RD; Perez JVD; Damasco JA; Yu G; Lin SC; Heralde FM; Novone NM; Santos EB; Lin SH; Melancon MP
    Int J Hyperthermia; 2021; 38(1):650-662. PubMed ID: 33882773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI-TRUS fusion for electrode positioning during irreversible electroporation for treatment of prostate cancer.
    Baur ADJ; Collettini F; Enders J; Maxeiner A; Schreiter V; Stephan C; Gebauer B; Hamm B; Fischer T
    Diagn Interv Radiol; 2017; 23(4):321-325. PubMed ID: 28508759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Irreversible electroporation: local tumor ablation with systemic immune effect].
    Geboers B; Timmer FEF; van den Tol PM; de Gruijl TD; Scheffer HJ; Meijerink MR
    Ned Tijdschr Geneeskd; 2021 Sep; 165():. PubMed ID: 34854585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort.
    Blazevski A; Scheltema MJ; Yuen B; Masand N; Nguyen TV; Delprado W; Shnier R; Haynes AM; Cusick T; Thompson J; Stricker P
    Eur Urol Oncol; 2020 Jun; 3(3):283-290. PubMed ID: 31103721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Target ablation--image-guided therapy in prostate cancer.
    Marien A; Gill I; Ukimura O; Betrouni N; Villers A
    Urol Oncol; 2014 Aug; 32(6):912-23. PubMed ID: 24411788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.